Taipei, Taiwan

I-Ming Chu

This inventor holds 1 USPTO granted patent. Top assignee: Sino-Cell Technologies. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: I-Ming Chu. Retrieved from https://idiyas.com/inventor/i-ming-chu-6s7z873b

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: I-Ming Chu: Innovator in Hematopoietic Cell Expansion

Introduction

I-Ming Chu is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of cell culture, particularly in optimizing conditions for hematopoietic cell expansion. His innovative work has implications for medical research and therapeutic applications.

Latest Patents

I-Ming Chu holds a patent titled "Optimizing culture medium for CD34+ hematopoietic cell expansion." This invention provides a method for determining the optimal composition of a serum-free, eukaryotic cell culture medium supplement. It utilizes a 2-level factorial design and the steepest ascent method. The patent also outlines methods for creating a serum-free eukaryotic cell culture medium supplement and the medium itself. Additionally, it includes a kit containing the medium and methods for expanding CD34+ hematopoietic cells in this optimized environment.

Career Highlights

I-Ming Chu is associated with Sino-Cell Technologies, where he applies his expertise in cell culture and innovation. His work has been instrumental in advancing the understanding and application of hematopoietic cell expansion techniques.

Collaborations

I-Ming Chu has collaborated with notable colleagues such as Shiaw-Min Hwang and Chi-Hsien Liu. Their combined efforts contribute to the ongoing research and development in the field of cell culture.

Conclusion

I-Ming Chu's contributions to the optimization of cell culture mediums represent a significant advancement in the field of hematopoietic cell research. His innovative patent and collaborative efforts continue to influence medical research and therapeutic practices.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…